XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Series A Redeemable Convertible Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 0 $ 50 $ (39,272) $ 651,156 $ (422,541) $ 1,847 $ 191,240
Beginning balance, shares at Dec. 31, 2018 0 49,639,319          
Net loss attributable to Acacia Research Corporation (10,141) (10,141)
Stock options exercised   79 79
Stock options exercised, shares   25,136          
Compensation expense for share-based awards, net of forfeitures   453 453
Compensation expense for share-based awards, net of forfeitures, shares   468,416          
Net income attributable to noncontrolling interests in subsidiaries   (14) (14)
Ending balance, value at Jun. 30, 2019 $ 0 $ 50 (39,272) 651,688 (432,682) 1,833 181,617
Ending balance, shares at Jun. 30, 2019 0 50,132,871          
Beginning balance, value at Mar. 31, 2019 $ 0 $ 50 (39,272) 651,148 (426,925) 1,833 186,834
Beginning balance, shares at Mar. 31, 2019 0 49,656,067          
Net loss attributable to Acacia Research Corporation (5,757) (5,757)
Stock options exercised   79 79
Stock options exercised, shares   25,136          
Compensation expense for share-based awards, net of forfeitures   461 461
Compensation expense for share-based awards, net of forfeitures, shares   451,668          
Net income attributable to noncontrolling interests in subsidiaries             (0)
Ending balance, value at Jun. 30, 2019 $ 0 $ 50 (39,272) 651,688 (432,682) 1,833 181,617
Ending balance, shares at Jun. 30, 2019 0 50,132,871          
Beginning balance, value at Dec. 31, 2019 $ 8,089 $ 50 (39,272) 652,003 (439,656) 1,833 174,958
Beginning balance, shares at Dec. 31, 2019 350,000 50,370,987          
Net loss attributable to Acacia Research Corporation   (5,143) (5,143)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value $ 1,311 (1,311) (1,311)
Dividend on Series A Redeemable Convertible Preferred Stock   (652) (652)
Stock options exercised   48 48
Stock options exercised, shares   0          
Compensation expense for share-based awards, net of forfeitures   755 755
Compensation expense for share-based awards, net of forfeitures, shares   619,687          
Repurchase of common stock   $ (1) (3,998) (3,999)
Repurchase of common stock, shares   (1,684,537)          
Net income attributable to noncontrolling interests in subsidiaries             (0)
Ending balance, value at Jun. 30, 2020 $ 9,400 $ 49 (43,270) 650,843 (444,799) 1,833 164,656
Ending balance, shares at Jun. 30, 2020 350,000 49,306,137          
Beginning balance, value at Mar. 31, 2020 $ 8,720 $ 50 (40,586) 651,441 (450,947) 1,833 161,791
Beginning balance, shares at Mar. 31, 2020 350,000 49,813,443          
Net loss attributable to Acacia Research Corporation 6,148 6,148
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value 680 (680) (680)
Dividend on Series A Redeemable Convertible Preferred Stock (389) (389)
Stock options exercised 48 48
Stock options exercised, shares 0 0          
Compensation expense for share-based awards, net of forfeitures 423 423
Compensation expense for share-based awards, net of forfeitures, shares 0 600,333          
Repurchase of common stock $ (1) (2,684) (2,685)
Repurchase of common stock, shares 0 (1,107,639)          
Net income attributable to noncontrolling interests in subsidiaries             (0)
Ending balance, value at Jun. 30, 2020 $ 9,400 $ 49 $ (43,270) $ 650,843 $ (444,799) $ 1,833 $ 164,656
Ending balance, shares at Jun. 30, 2020 350,000 49,306,137